| Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors DL Montgomery, JW SHIVER, KR LEANDER, HC PERRY, A FRIEDMAN, ... DNA and cell biology 12 (9), 777-783, 1993 | 411 | 1993 |
| Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer AJ Walsh, RS Cook, ME Sanders, L Aurisicchio, G Ciliberto, CL Arteaga, ... Cancer research 74 (18), 5184-5194, 2014 | 299 | 2014 |
| Comparative expression pathway analysis of human and canine mammary tumors P Uva, L Aurisicchio, J Watters, A Loboda, A Kulkarni, J Castle, ... BMC genomics 10, 1-20, 2009 | 202 | 2009 |
| SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines G Salvatori, L Luberto, M Maffei, L Aurisicchio, G Roscilli, F Palombo, ... Journal of translational medicine 18 (1), 222, 2020 | 199 | 2020 |
| Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells A Noto, S Raffa, C De Vitis, G Roscilli, D Malpicci, P Coluccia, A Di Napoli, ... Cell death & disease 4 (12), e947-e947, 2013 | 159 | 2013 |
| Time to Blood Culture Positivity as a Predictor of Clinical Outcome of Staphylococcus aureus Bloodstream Infection AR Marra, MB Edmond, BA Forbes, RP Wenzel, GML Bearman Journal of clinical microbiology 44 (4), 1342-1346, 2006 | 156 | 2006 |
| Baculovirus vectors elicit antigen-specific immune responses in mice A Facciabene, L Aurisicchio, N La Monica Journal of virology 78 (16), 8663-8672, 2004 | 136 | 2004 |
| Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure G Rizzuto, M Cappelletti, C Mennuni, MI Wiznerowicz, A Demartis, ... Human gene therapy 11 (13), 1891-1900, 2000 | 115 | 2000 |
| Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer S Lanzardo, L Conti, R Rooke, R Ruiu, N Accart, E Bolli, M Arigoni, ... Cancer research 76 (1), 62-72, 2016 | 113 | 2016 |
| MMP11: a novel target antigen for cancer immunotherapy D Peruzzi, F Mori, A Conforti, D Lazzaro, E De Rinaldis, G Ciliberto, ... Clinical Cancer Research 15 (12), 4104-4113, 2009 | 102 | 2009 |
| The perfect personalized cancer therapy: cancer vaccines against neoantigens L Aurisicchio, M Pallocca, G Ciliberto, F Palombo Journal of Experimental & Clinical Cancer Research 37, 1-10, 2018 | 98 | 2018 |
| Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system V Salucci, A Scarito, L Aurisicchio, S Lamartina, G Nicolaus, S Giampaoli, ... Gene Therapy 9 (21), 1415-1421, 2002 | 97 | 2002 |
| Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors CM Diaz, A Chiappori, L Aurisicchio, A Bagchi, J Clark, S Dubey, ... Journal of translational medicine 11, 1-13, 2013 | 95 | 2013 |
| The promise of anti-ErbB3 monoclonals as new cancer therapeutics L Aurisicchio, E Marra, G Roscilli, R Mancini, G Ciliberto Oncotarget 3 (8), 744, 2012 | 93 | 2012 |
| A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma D Peruzzi, A Gavazza, G Mesiti, G Lubas, E Scarselli, A Conforti, ... Molecular Therapy 18 (8), 1559-1567, 2010 | 92 | 2010 |
| Gene electro‐transfer improves transduction by modifying the fate of intramuscular DNA M Cappelletti, I Zampaglione, G Rizzuto, G Ciliberto, NL Monica, E Fattori The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2003 | 92 | 2003 |
| Epigenetic silencing of miR-145-5p contributes to brain metastasis S Donzelli, F Mori, T Bellissimo, A Sacconi, B Casini, T Frixa, G Roscilli, ... Oncotarget 6 (34), 35183, 2015 | 82 | 2015 |
| Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis L Aurisicchio, P Delmastro, V Salucci, OG Paz, P Rovere, G Ciliberto, ... Journal of virology 74 (10), 4816-4823, 2000 | 81 | 2000 |
| Genetic cancer vaccines: current status and perspectives L Aurisicchio, G Ciliberto Expert opinion on biological therapy 12 (8), 1043-1058, 2012 | 80 | 2012 |
| Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies L Fattore, E Marra, ME Pisanu, A Noto, C de Vitis, F Belleudi, L Aurisicchio, ... Journal of translational medicine 11, 1-11, 2013 | 78 | 2013 |
